Handheld Adipose Stem Cell Processor for Point of Care Application

Period of Performance: 12/03/2013 - 07/02/2014


Phase 1 SBIR

Recipient Firm

Tissue Genesis, Inc.
810 Richards St.
Honolulu, HI 96813
Principal Investigator


Tissue Genesis® (TGI) is proposing to develop a highly portable, easy to use, low-cost, point-of-care, adipose-derived stem cell (ASC) isolation device that fully integrates the process from fat extraction to cell product. This next generation system addresses current technology limitations including: sterility breaks, acquisition and process time, complexity of operation, and cost. The convenient and rapid recovery of millions of regenerative cells will fill the unmet need as a readily available source of adult stem cells for therapeutic use across multiple military trauma needs, such as wound healing, tissue and nerve repair, orthopedic injury repair, plastics and aesthetics, ophthalmology, and otolaryngology. The proposed system addresses current technology, cost, and convenience shortfalls and allows for a rapid translation of regenerative stem cell therapeutics into the clinic.